Goldshield Attracting Attention From Neopharm

UK based generic drug manufacturer Goldshield has been approached by Israeli-based Neopharm for acquisition. In an added twist to the potential buy-out, Neopharm's bid is under a joint alliance with AIT Investments , which is headed by the former CEO of Goldshields who had stepped down in 2007.

To read the full article, please choose one of the following options: